Study: How Shigella Causes Dysentery
Posted on: Thursday, 14 December 2006, 12:00 CST
French scientists say they believe they've discovered how shigella bacteria survive in the gut to be able to cause dysentery.
Laurence Arbibe and colleagues at the Pasteur Institute in Paris found a protein produced by shigella is injected into host cells and blocks production of immune signals required for preventing the infection.
Shigella affects millions of people worldwide, killing hundreds of thousands annually.
The researchers studied Shigella flexneri infection of human colon cells to understand the bacterial factors required to initiate disease. Shigella bacteria are known to inject up to 20 proteins into intestinal cells for the purpose of promoting infection and for dampening immune responses.
They found one of the injected proteins, OpsF, could prevent gut cells from switching on genes involved in immune responses. As a consequence, Shigella flexneri avoids being killed by their host's immune cells and is able to spread throughout the gut.
The scientists say their study highlights the precision with which pathogens such as shigella can dramatically alter host cells. It also suggests blocking OspF may provide a target for treating bacterial dysentery.
The study is reported in the January issue of the journal Nature Immunology.
Source: United Press International
Related Articles
- Mechanism Discovered By Which Body's Cells Encourage Tuberculosis Infection
- Study Eliminating Cell Receptor Prevents Infection In Animals
- Eliminating Cell Receptor Prevents Infections in Animal Study
- Living Cell Technologies Hosts Diabetes Seminar for World Leaders in Porcine Islet Implants in Humans
- Cell Immune Dampening Signal Identified
- Vical DNA Vaccine Elicits Lasting Memory T-Cell Immune Responses in Humans
- Broad T-Cell Immunity Against HIV Generated in Prime-Boost Vaccine Phase 1 Trial
- Fuel Cell Industry Hosts Congressional EXPO; Capitol Hill Will Get First-Hand Look at Industry Progress
- Sangamo BioSciences Announces Breakthrough Results at ICAAC Demonstrating Protection of Cells From HIV Infection Following Treatment With Zinc Finger Nucleases
- Group IB Secretory Phospholipase A2 Inhibits Human Dendritic Cell Immune Functions
User Comments (0)

RSS Feeds